Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

254 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Impact of an artificial intelligence based model to predict non-transplantable recurrence among patients with hepatocellular carcinoma.
Altaf A, Endo Y, Munir MM, Khan MMM, Rashid Z, Khalil M, Guglielmi A, Ratti F, Marques H, Cauchy F, Lam V, Poultsides G, Kitago M, Popescu I, Martel G, Gleisner A, Hugh T, Shen F, Endo I, Pawlik TM. Altaf A, et al. Among authors: kitago m. HPB (Oxford). 2024 Aug;26(8):1040-1050. doi: 10.1016/j.hpb.2024.05.006. Epub 2024 May 16. HPB (Oxford). 2024. PMID: 38796346
Clinicopathological impacts of DNA methylation alterations on pancreatic ductal adenocarcinoma: prediction of early recurrence based on genome-wide DNA methylation profiling.
Endo Y, Fujimoto M, Ito N, Takahashi Y, Kitago M, Gotoh M, Hiraoka N, Yoshida T, Kitagawa Y, Kanai Y, Arai E. Endo Y, et al. Among authors: kitago m. J Cancer Res Clin Oncol. 2021 May;147(5):1341-1354. doi: 10.1007/s00432-021-03541-6. Epub 2021 Feb 26. J Cancer Res Clin Oncol. 2021. PMID: 33635431 Free PMC article.
[No title available]
[No authors listed] [No authors listed] PMID: 36097298
A Novel Online Calculator to Predict Risk of Microvascular Invasion in the Preoperative Setting for Hepatocellular Carcinoma Patients Undergoing Curative-Intent Surgery.
Endo Y, Alaimo L, Lima HA, Moazzam Z, Ratti F, Marques HP, Soubrane O, Lam V, Kitago M, Poultsides GA, Popescu I, Alexandrescu S, Martel G, Workneh A, Guglielmi A, Hugh T, Aldrighetti L, Endo I, Pawlik TM. Endo Y, et al. Among authors: kitago m. Ann Surg Oncol. 2023 Feb;30(2):725-733. doi: 10.1245/s10434-022-12494-0. Epub 2022 Sep 14. Ann Surg Oncol. 2023. PMID: 36103014
Tumor Burden Score and Serum Alpha-fetoprotein Subclassify Intermediate-Stage Hepatocellular Carcinoma.
Lima HA, Endo Y, Alaimo L, Moazzam Z, Munir MM, Shaikh C, Resende V, Guglielmi A, Marques HP, Cauchy F, Lam V, Poultsides GA, Popescu I, Alexandrescu S, Martel G, Hugh T, Endo I, Kitago M, Shen F, Pawlik TM. Lima HA, et al. Among authors: kitago m. J Gastrointest Surg. 2022 Dec;26(12):2512-2521. doi: 10.1007/s11605-022-05469-9. Epub 2022 Sep 28. J Gastrointest Surg. 2022. PMID: 36171471
TAC score better predicts survival than the BCLC following resection of hepatocellular carcinoma.
Lima HA, Endo Y, Moazzam Z, Alaimo L, Shaikh C, Munir MM, Resende V, Guglielmi A, Marques HP, Cauchy F, Lam V, Poultsides GA, Popescu I, Alexandrescu S, Martel G, Endo I, Kitago M, Shen F, Pawlik TM. Lima HA, et al. Among authors: kitago m. J Surg Oncol. 2023 Mar;127(3):374-384. doi: 10.1002/jso.27116. Epub 2022 Oct 4. J Surg Oncol. 2023. PMID: 36194039 Free PMC article.
Predictive risk-score model to select patients with intrahepatic cholangiocarcinoma for adjuvant chemotherapy.
Endo Y, Moazzam Z, Alaimo L, Lima HA, Munir MM, Shaikh CF, Guglielmi A, Aldrighetti L, Weiss M, Bauer TW, Alexandrescu S, Poultsides GA, Kitago M, Maithel SK, Marques HP, Martel G, Pulitano C, Shen F, Cauchy F, Koerkamp BG, Endo I, Pawlik TM. Endo Y, et al. Among authors: kitago m. HPB (Oxford). 2023 Feb;25(2):229-238. doi: 10.1016/j.hpb.2022.10.011. Epub 2022 Nov 3. HPB (Oxford). 2023. PMID: 36396550 Free article.
Higher Tumor Burden Status Dictates the Impact of Surgical Margin Status on Overall Survival in Patients Undergoing Resection of Intrahepatic Cholangiocarcinoma.
Endo Y, Sasaki K, Moazzam Z, Lima HA, Alaimo L, Guglielmi A, Aldrighetti L, Weiss M, Bauer TW, Alexandrescu S, Poultsides GA, Kitago M, Maithel SK, Marques HP, Martel G, Pulitano C, Shen F, Cauchy F, Koerkamp BG, Endo I, Pawlik TM. Endo Y, et al. Among authors: kitago m. Ann Surg Oncol. 2023 Apr;30(4):2023-2032. doi: 10.1245/s10434-022-12803-7. Epub 2022 Nov 17. Ann Surg Oncol. 2023. PMID: 36396868
254 results